+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Diabetic Footwear Market Size, Share & Industry Trends Analysis Report By End User, By Type (Shoes, Sandals and Slippers), By Distribution Channel (Specialty Stores, Footwear Stores and Others), By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 139 Pages
  • December 2023
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5916933
The Asia Pacific Diabetic Footwear Market would witness market growth of 8.8% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 40,511.5 thousand Units, showcasing a growth of 8.6% (2019-2022).

Diabetic shoes are typically designed with minimal seams or with seams placed in such a way as to minimize friction and irritation against the skin. This is crucial for preventing the formation of blisters and sores, which can be exacerbated in individuals with reduced sensation. Diabetic footwear often features wider toe boxes to accommodate any deformities or swelling that may occur in individuals with diabetes. This helps to prevent the toes from rubbing against the shoe, reducing the risk of friction-related injuries.

Diabetic footwear often utilizes materials that promote breathability and moisture control, preventing the accumulation of moisture that could lead to fungal infections. This holds particular significance for individuals diagnosed with diabetes, given their heightened vulnerability to complications pertaining to the epidermis. Specialized designs aim to minimize shear and friction, reducing the risk of blisters and calluses. This preventive approach aligns with the overarching goal of diabetic footwear to protect the foot from potential harm. The market is dynamic, witnessing several trends that shape product development and consumer preferences.

As per the data from the Government of Australia, the National Diabetes Services Scheme (NDSS) and Australasian Paediatric Endocrine Group (APEG) state-based registers recorded that in 2021, approximately 1 in 20 Australians (approximately 1.3 million) were living with diabetes (prevalence). With nearly one in every five Australians aged 80–84 having diabetes in 2021, the incidence rate was nearly thirty times that of those aged below 40 (0.7%). Upon accounting for age, the prevalence of diabetes in males was 1.3 times that of females. Thus, the increasing prevalence of diabetes in the Asia Pacific region will positively impact the regional market.

The China market dominated the Asia Pacific Diabetic Footwear Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $929.6 Million by 2030. The Japan market is registering a CAGR of 8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.4% during (2023 - 2030).

Based on End User, the market is segmented into Women and Men. Based on Type, the market is segmented into Shoes, Sandals and Slippers. Based on Distribution Channel, the market is segmented into Specialty Stores, Online Platform, Footwear Stores and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New Balance Athletics, Inc., SKECHERS USA, Inc., Orthofeet, Inc. (Webster Equity Partners), DJO Global (Enovis Corporation), Drew Shoe Corporation, Wolverine World Wide, Inc., Podartis Srl, I-Runner (Healer Health LLC), Pilgrim Shoes and Aetrx Worldwide, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End User (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Women
  • Men
By Type (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Shoes
  • Sandals
  • Slippers
By Distribution Channel (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • Specialty Stores
  • Online Platform
  • Footwear Stores
  • Others
By Country (Volume, Thousand Units, USD Billion/Million, 2019-2030)
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • New Balance Athletics, Inc.
  • SKECHERS USA, Inc.
  • Orthofeet, Inc. (Webster Equity Partners)
  • DJO Global (Enovis Corporation)
  • Drew Shoe Corporation
  • Wolverine World Wide, Inc.
  • Podartis Srl
  • I-Runner (Healer Health LLC)
  • Pilgrim Shoes
  • Aetrx Worldwide, Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Diabetic Footwear Market, by End User
1.4.2 Asia Pacific Diabetic Footwear Market, by Type
1.4.3 Asia Pacific Diabetic Footwear Market, by Distribution Channel
1.4.4 Asia Pacific Diabetic Footwear Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Strategies Deployed in Diabetic Footwear Market
Chapter 5. Asia Pacific Diabetic Footwear Market by End User
5.1 Asia Pacific Women Market by Country
5.2 Asia Pacific Men Market by Country
Chapter 6. Asia Pacific Diabetic Footwear Market by Type
6.1 Asia Pacific Shoes Market by Country
6.2 Asia Pacific Sandals Market by Country
6.3 Asia Pacific Slippers Market by Country
Chapter 7. Asia Pacific Diabetic Footwear Market by Distribution Channel
7.1 Asia Pacific Specialty Stores Market by Country
7.2 Asia Pacific Online Platform Market by Country
7.3 Asia Pacific Footwear Stores Market by Country
7.4 Asia Pacific Others Market by Country
Chapter 8. Asia Pacific Diabetic Footwear Market by Country
8.1 China Diabetic Footwear Market
8.1.1 China Diabetic Footwear Market by End User
8.1.2 China Diabetic Footwear Market by Type
8.1.3 China Diabetic Footwear Market by Distribution Channel
8.2 Japan Diabetic Footwear Market
8.2.1 Japan Diabetic Footwear Market by End User
8.2.2 Japan Diabetic Footwear Market by Type
8.2.3 Japan Diabetic Footwear Market by Distribution Channel
8.3 India Diabetic Footwear Market
8.3.1 India Diabetic Footwear Market by End User
8.3.2 India Diabetic Footwear Market by Type
8.3.3 India Diabetic Footwear Market by Distribution Channel
8.4 South Korea Diabetic Footwear Market
8.4.1 South Korea Diabetic Footwear Market by End User
8.4.2 South Korea Diabetic Footwear Market by Type
8.4.3 South Korea Diabetic Footwear Market by Distribution Channel
8.5 Singapore Diabetic Footwear Market
8.5.1 Singapore Diabetic Footwear Market by End User
8.5.2 Singapore Diabetic Footwear Market by Type
8.5.3 Singapore Diabetic Footwear Market by Distribution Channel
8.6 Malaysia Diabetic Footwear Market
8.6.1 Malaysia Diabetic Footwear Market by End User
8.6.2 Malaysia Diabetic Footwear Market by Type
8.6.3 Malaysia Diabetic Footwear Market by Distribution Channel
8.7 Rest of Asia Pacific Diabetic Footwear Market
8.7.1 Rest of Asia Pacific Diabetic Footwear Market by End User
8.7.2 Rest of Asia Pacific Diabetic Footwear Market by Type
8.7.3 Rest of Asia Pacific Diabetic Footwear Market by Distribution Channel
Chapter 9. Company Profiles
9.1 New Balance Athletics, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Product Launches and Product Expansions:
9.1.3 SWOT Analysis
9.2 SKECHERS USA, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Partnerships, Collaborations, and Agreements:
9.2.4.2 Acquisition and Mergers:
9.2.5 SWOT Analysis
9.3 Orthofeet, Inc. (Webster Equity Partners)
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 DJO Global (Enovis Corporation)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 Drew Shoe Corporation
9.5.1 Company Overview
9.5.2 SWOT Analysis
9.6 Wolverine World Wide, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 SWOT Analysis
9.7 Podartis Srl
9.7.1 Company Overview
9.7.2 SWOT Analysis
9.8 I-Runner (Healer Health LLC)
9.8.1 Company Overview
9.8.2 SWOT Analysis
9.9 Pilgrim Shoes
9.9.1 Company Overview
9.9.2 SWOT Analysis
9.10. Aetrex Worldwide, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Partnerships, Collaborations, and Agreements:
9.10.2.2 Product Launches and Product Expansions:
9.10.3 SWOT Analysis

Companies Mentioned

  • New Balance Athletics, Inc.
  • SKECHERS USA, Inc.
  • Orthofeet, Inc. (Webster Equity Partners)
  • DJO Global (Enovis Corporation)
  • Drew Shoe Corporation
  • Wolverine World Wide, Inc.
  • Podartis Srl
  • I-Runner (Healer Health LLC)
  • Pilgrim Shoes
  • Aetrx Worldwide, Inc.

Methodology

Loading
LOADING...